CEO David Hallal sold $280K of Alexion Pharmaceuticals, Inc.

Sold$279,800

$138.93Price

2,014Shares

−1%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Mon, Feb 29. Filed Tue, Mar 1, 6:32 PM ET, after the close. Not investment advice.